The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Adipocyte and lipid metabolism in cancer drug resistance
Open accessAbstract
Development of novel and effective therapeutics for treating various cancers is probably the most congested and challenging enterprise of pharmaceutical companies. Diverse drugs targeting malignant and nonmalignant cells receive clinical approval each year from the FDA. Targeting cancer cells and nonmalignant cells unavoidably changes the tumor microenvironment, and cellular and molecular components relentlessly alter in response to drugs. Cancer cells often reprogram their metabolic pathways to adapt to environmental challenges and facilitate survival, proliferation, and metastasis. While cancer cells' dependence on glycolysis for energy production is well studied, the roles of adipocytes and lipid metabolic reprogramming in supporting cancer growth, metastasis, and drug responses are less understood. This Review focuses on emerging mechanisms involving adipocytes and lipid metabolism in altering the response to cancer treatment. In particular, we discuss mechanisms underlying cancer-associated adipocytes and lipid metabolic reprogramming in cancer drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Even though the tumor tissue is hypervascularized, the disorganized, tortuous, and leaky tumor vasculature is poorly perfused, and drug perfusion is limited (129, 130).”
BackgroundNivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Intrinsic and acquired AAD resistance often occurs in cancer patients and considerably hampers therapeutic efficacy (164, 165).”
BackgroundFatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“The crucial lipogenic enzymes, including acetylCoA carboxylase, fatty acid synthase (FASN), and ATP citrate lyase, are ubiquitously expressed in most, if not all, cancer cells (2, 60, 61).”
BackgroundCCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D., Reeves, J., Hawkins, R., Guo, J., Nathan, P., Staehler, M., de Souza, P., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,923
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Cancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C. S.-O., Berenguer, A., Prats, N., Toll, A., Hueto, J. A., et al. (2017) · Nature · doi:10.1038/nature20791 · Cited by 1,437
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion
Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y. Y., Meulle, A., Salles, B., Le Gonidec, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3323 · Cited by 1,134
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Cannarile, M. A., Weisser, M., Jacob, W., Jegg, A.-M., Ries, C. H., & Rüttinger, D. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0257-y · Cited by 1,020
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Yue, S., Li, J., Lee, S.-Y., Lee, H. J., Shao, T., Song, B., Cheng, L., Masterson, T. A., Liu, X., Ratliff, T. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.019 · Cited by 929
The roles of TGFβ in the tumour microenvironment
Pickup, M., Novitskiy, S., & Moses, H. L. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3603 · Cited by 917
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
CD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 14×
“3 and Figure 3): (a) hypoxia promotes lipolysis in adipocytes, which release glycerol and FFAs as final metabolites; (b) cancer cells increase FFA uptake by upregulating CD36; and (c) cancer cells undergo reprogramming of metabolic pathways, activating the β-oxidation pathway to produce FFA metabolism– dependent energ…”
BackgroundInfluentialAu Yeung, C. L., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S.-Y., Leung, C. S., Li, Y., Lu, E. S., Kwan, K., Wong, K.-K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11150 · Cited by 774
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Hanley, M. J., Abernethy, D. R., & Greenblatt, D. J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318100-000000000-00000 · Cited by 773
A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
Petruzzelli, M., Schweiger, M., Schreiber, R., Campos-Olivas, R., Tsoli, M., Allen, J., Swarbrick, M., Rose-John, S., Rincon, M., Robertson, G., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.011 · Cited by 750
Adipose tissue and adipocytes support tumorigenesis and metastasis
Nieman, K. M., Romero, I. L., Van Houten, B., & Lengyel, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.010 · Cited by 749
Angiogenesis modulates adipogenesis and obesity
Cao, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32239 · Cited by 736 · cited 3×
“30–44 and Table 1); (c) metabolic reprogramming in cancer cells (2, 3); (d) protease production necessary for cancer invasion (45, 46); and (e) recruitment of nonadipocyte stromal cells such as inflammatory cells and vascular cells (47, 48).”
BackgroundSelf-citationTumor Immunotherapy Directed at PD-1
Ribas, A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1205943 · Cited by 683
Fatty Acid Synthase and Cancer: New Application of an Old Pathway
Kuhajda, F. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4673 · Cited by 647
Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 611
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
Mukhopadhyay, D., Tsiokas, L., Zhou, X.-M., Foster, D., Brugge, J. S., & Sukhatme, V. P. (1995) · Nature · doi:10.1038/375577a0 · Cited by 595
ATP-Citrate Lyase: A Key Player in Cancer Metabolism
Zaidi, N., Swinnen, J. V., & Smans, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4112 · Cited by 545
Bochet, L., Lehuédé, C., Dauvillier, S., Wang, Y. Y., Dirat, B., Laurent, V., Dray, C., Guiet, R., Maridonneau-Parini, I., Le Gonidec, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0530 · Cited by 529
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K., Tondera, D., Gounarides, J., Yin, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 528
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
Ladanyi, A., Mukherjee, A., Kenny, H. A., Johnson, A., Mitra, A. K., Sundaresan, S., Nieman, K. M., Pascual, G., Benitah, S. A., Montag, A., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0093-z · Cited by 517
Peroxisomal β-oxidation—A metabolic pathway with multiple functions
Poirier, Y., Antonenkov, V. D., Glumoff, T., & Hiltunen, J. K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.034 · Cited by 499
Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
Heilbronn, L., & Campbell, L. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246153 · Cited by 496
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 490
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis
Stein, U., Walther, W., Arlt, F., Schwabe, H., Smith, J., Fichtner, I., Birchmeier, W., & Schlag, P. M. (2009) · Nature Medicine · doi:10.1038/nm.1889 · Cited by 480
Interplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K.-L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 472
Balaban, S., Shearer, R. F., Lee, L. S., van Geldermalsen, M., Schreuder, M., Shtein, H. C., Cairns, R., Thomas, K. C., Fazakerley, D. J., Grewal, T., et al. (2017) · Cancer & Metabolism · doi:10.1186/s40170-016-0163-7 · Cited by 416
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 401
Yamamori, T., Yasui, H., Yamazumi, M., Wada, Y., Nakamura, Y., Nakamura, H., & Inanami, O. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.033 · Cited by 396
A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
Christofori, G., Naik, P., & Hanahan, D. (1994) · Nature · doi:10.1038/369414a0 · Cited by 390
Hypoxia-Independent Angiogenesis in Adipose Tissues during Cold Acclimation
Xue, Y., Petrovic, N., Cao, R., Larsson, O., Lim, S., Chen, S., Feldmann, H. M., Liang, Z., Zhu, Z., Nedergaard, J., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.009 · Cited by 384
Self-citationImpact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
Lyman, G. H. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0009 · Cited by 383
Targeting glucose metabolism for cancer therapy
Hamanaka, R. B., & Chandel, N. S. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120162 · Cited by 369
Lipid Droplets in Cancer: Guardians of Fat in a Stressful World
Petan, T., Jarc, E., & Jusović, M. (2018) · Molecules · doi:10.3390/molecules23081941 · Cited by 368
Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins
Zhang, M., Di Martino, J. S., Bowman, R. L., Campbell, N. R., Baksh, S. C., Simon-Vermot, T., Kim, I. S., Haldeman, P., Mondal, C., Yong-Gonzales, V., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1371 · Cited by 360
Van der Veldt, A. A. M., Lubberink, M., Bahce, I., Walraven, M., de Boer, M. P., Greuter, H. N. J. M., Hendrikse, N. H., Eriksson, J., Windhorst, A. D., Postmus, P. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.023 · Cited by 337
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 335
Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice
Bråkenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., Parini, P., & Cao, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000132745.76882.70 · Cited by 326
Self-citationThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
Gordon, J. N., Trebble, T. M., Ellis, R. D., Duncan, H. D., Johns, T., & Goggin, P. M. (2005) · Gut · doi:10.1136/gut.2004.047563 · Cited by 322
Cao, Y. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.008 · Cited by 319
Self-citationPark, J. H., Vithayathil, S., Kumar, S., Sung, P.-L., Dobrolecki, L. E., Putluri, V., Bhat, V. B., Bhowmik, S. K., Gupta, V., Arora, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.004 · Cited by 313
Inter-tissue communication in cancer cachexia
Argilés, J. M., Stemmler, B., López-Soriano, F. J., & Busquets, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0123-0 · Cited by 305
Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
Iwamoto, H., Abe, M., Yang, Y., Cui, D., Seki, T., Nakamura, M., Hosaka, K., Lim, S., Wu, J., He, X., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.005 · Cited by 300
Self-citationPeriprostatic adipocytes act as a driving force for prostate cancer progression in obesity
Laurent, V., Guérard, A., Mazerolles, C., Le Gonidec, S., Toulet, A., Nieto, L., Zaidi, F., Majed, B., Garandeau, D., Socrier, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms10230 · Cited by 296
Megestrol acetate for treatment of anorexia-cachexia syndrome
Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004310.pub3 · Cited by 293
The Role of Obesity in Cancer Survival and Recurrence
Demark-Wahnefried, W., Platz, E. A., Ligibel, J. A., Blair, C. K., Courneya, K. S., Meyerhardt, J. A., Ganz, P. A., Rock, C. L., Schmitz, K. H., Wadden, T., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0485 · Cited by 290
The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj, D. M., Weinreich, D. M., Varghese, S., Puhlmann, M., Hewitt, S. M., Carroll, N. M., Feldman, E. D., Turner, E. M., & Alexander, H. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1603 · Cited by 288
The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_9 · Cited by 287
Inflammatory lipid mediators in adipocyte function and obesity
Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D., & Brown, L. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.264 · Cited by 285
Adipocyte biology in breast cancer: From silent bystander to active facilitator
Choi, J., Cha, Y. J., & Koo, J. S. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.11.002 · Cited by 255
Mitochondrial biogenesis in exercise and in ageing☆
Viña, J., Gomez-Cabrera, M. C., Borras, C., Froio, T., Sanchis-Gomar, F., Martinez-Bello, V. E., & Pallardo, F. V. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.006 · Cited by 253
Adipocyte Ceramides Regulate Subcutaneous Adipose Browning, Inflammation, and Metabolism
Chaurasia, B., Kaddai, V. A., Lancaster, G. I., Henstridge, D. C., Sriram, S., Galam, D. L. A., Gopalan, V., Prakash, K. N. B., Velan, S. S., Bulchand, S., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.002 · Cited by 247
Guiu, B., Petit, J. M., Bonnetain, F., Ladoire, S., Guiu, S., Cercueil, J.-P., Krausé, D., Hillon, P., Borg, C., Chauffert, B., et al. (2010) · Gut · doi:10.1136/gut.2009.188946 · Cited by 245
Cytoskeletal Control of CD36 Diffusion Promotes Its Receptor and Signaling Function
Jaqaman, K., Kuwata, H., Touret, N., Collins, R., Trimble, W. S., Danuser, G., & Grinstein, S. (2011) · Cell · doi:10.1016/j.cell.2011.06.049 · Cited by 244
Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia
Butturini, A. M., Dorey, F. J., Lange, B. J., Henry, D. W., Gaynon, P. S., Fu, C., Franklin, J., Siegel, S. E., Seibel, N. L., Rogers, P. C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7792 · Cited by 223
Forty-Year Journey of Angiogenesis Translational Research
Cao, Y., Arbiser, J., D’Amato, R. J., D’Amore, P. A., Ingber, D. E., Kerbel, R., Klagsbrun, M., Lim, S., Moses, M. A., Zetter, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003149 · Cited by 223
Self-citationIncio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0945 · Cited by 222
Farooqui, M., Li, Y., Rogers, T., Poonawala, T., Griffin, R. J., Song, C. W., & Gupta, K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604057 · Cited by 211
Implications of Obesity for Drug Therapy: Limitations and Challenges
Jain, R., Chung, S. M., Jain, L., Khurana, M., Lau, S. W. J., Lee, J. E., Vaidyanathan, J., Zadezensky, I., Choe, S., & Sahajwalla, C. G. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.104 · Cited by 210
FABP4 as a key determinant of metastatic potential of ovarian cancer
Gharpure, K. M., Pradeep, S., Sans, M., Rupaimoole, R., Ivan, C., Wu, S. Y., Bayraktar, E., Nagaraja, A. S., Mangala, L. S., Zhang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04987-y · Cited by 210
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
Abramson, J. S., McGree, B., Noyes, S., Plummer, S., Wong, C., Chen, Y.-B., Palmer, E., Albertson, T., Ferry, J. A., & Arrillaga-Romany, I. C. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1704610 · Cited by 206
Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors
Sinicrope, F. A., Foster, N. R., Sargent, D. J., O'Connell, M. J., & Rankin, C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2636 · Cited by 202
Bui, T., & Thompson, C. B. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.012 · Cited by 195
Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression
Riondino, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5177 · Cited by 193
The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance
Duong, M. N., Geneste, A., Fallone, F., Li, X., Dumontet, C., & Muller, C. (2017) · Oncotarget · doi:10.18632/oncotarget.18038 · Cited by 193
Yang, Y., Andersson, P., Hosaka, K., Zhang, Y., Cao, R., Iwamoto, H., Yang, X., Nakamura, M., Wang, J., Zhuang, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11385 · Cited by 186
Self-citationDirect Visualization of De novo Lipogenesis in Single Living Cells
Li, J., & Cheng, J.-X. (2014) · Scientific Reports · doi:10.1038/srep06807 · Cited by 185
Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine
Ehsanipour, E. A., Sheng, X., Behan, J. W., Wang, X., Butturini, A., Avramis, V. I., & Mittelman, S. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4402 · Cited by 185
Parekh, N., Chandran, U., & Bandera, E. V. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150713 · Cited by 184
Review article: Obesity as a risk factor for development and poor prognosis of breast cancer
Carmichael, A. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01021.x · Cited by 183
Adipocytes Impair Leukemia Treatment in Mice
Behan, J. W., Yun, J. P., Proektor, M. P., Ehsanipour, E. A., Arutyunyan, A., Moses, A. S., Avramis, V. I., Louie, S. G., Butturini, A., Heisterkamp, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0800 · Cited by 183
Liu, Y., Zuckier, L. S., & Ghesani, N. V. (2010) · PubMed · Cited by 183
Obesity-associated Breast Cancer: Analysis of risk factors
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_25 · Cited by 178
Exposure to Heavy Ion Radiation Induces Persistent Oxidative Stress in Mouse Intestine
Datta, K., Suman, S., Kallakury, B. V. S., & Fornace, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042224 · Cited by 175
Metabolic syndrome and risk of cancer: Which link?
Mendonça, F. M., de Sousa, F. R., Barbosa, A. L., Martins, S. C., Araújo, R. L., Soares, R., & Abreu, C. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.008 · Cited by 172
Palanichamy, J. K., Tran, T. M., Howard, J. M., Contreras, J. R., Fernando, T. R., Sterne-Weiler, T., Katzman, S., Toloue, M., Yan, W., Basso, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80046 · Cited by 168
Hao, J., Yan, F., Zhang, Y., Triplett, A., Zhang, Y., Schultz, D. A., Sun, Y., Zeng, J., Silverstein, K. A. T., Zheng, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2465 · Cited by 168
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Liu, Z., Xu, J., He, J., Liu, H., Lin, P., Wan, X., Navone, N. M., Tong, Q., Kwak, L. W., Orlowski, R. Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6020 · Cited by 164
Association of body mass index and survival in pediatric leukemia: a meta-analysis
Orgel, E., Genkinger, J. M., Aggarwal, D., Sung, L., Nieder, M., & Ladas, E. J. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.124586 · Cited by 163
Ladoire, S., Bonnetain, F., Gauthier, M., Zanetta, S., Petit, J. M., Guiu, S., Kermarrec, I., Mourey, E., Michel, F., Krause, D., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0227 · Cited by 162
Ryan, S. (2017) · The Journal of Physiology · doi:10.1113/jp273312 · Cited by 159
The potential role of leptin in tumor invasion and metastasis
Ray, A., & Cleary, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.11.002 · Cited by 158
Hao, J., Zhang, Y., Yan, X., Yan, F., Sun, Y., Zeng, J., Waigel, S., Yin, Y., Fraig, M. M., Egilmez, N. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.006 · Cited by 158
Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones
Yakar, S., Núñez, N. P., Pennisi, P. A., Brodt, P., Sun, H., Fallavollita, L., Zhao, H., Scavo, L. M., Novosyadlyy, R., Kurshan, N., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0311 · Cited by 155
Rani, R., & Kumar, V. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00168 · Cited by 141
Cancer-associated adipocytes promotes breast tumor radioresistance
Bochet, L., Meulle, A., Imbert, S., Salles, B., Valet, P., & Muller, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.101 · Cited by 140
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
Doktorová, H., Hraběta, J., Khalil, M. A., & Eckschlager, T. (2015) · Biomedical Papers · doi:10.5507/bp.2015.025 · Cited by 137
Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle
Motrescu, E. R., & Rio, M. (2008) · Biological Chemistry · doi:10.1515/bc.2008.110 · Cited by 135
The metabolic advantage of tumor cells
Israël, M., & Schwartz, L. H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-70 · Cited by 134
Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
Ando, K., Takahashi, F., Kato, M., Kaneko, N., Doi, T., Ohe, Y., Koizumi, F., Nishio, K., & Takahashi, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102436 · Cited by 133
Molecular mechanisms of IL-33–mediated stromal interactions in cancer metastasis
Andersson, P., Yang, Y., Hosaka, K., Zhang, Y., Fischer, C., Braun, H., Liu, S., Yu, G., Liu, S., Beyaert, R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122375 · Cited by 133
Self-citationEngin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_13 · Cited by 130
Goto, H., Shimono, Y., Funakoshi, Y., Imamura, Y., Toyoda, M., Kiyota, N., Kono, S., Takao, S., Mukohara, T., & Minami, H. (2018) · Oncogene · doi:10.1038/s41388-018-0477-8 · Cited by 130
Huang, C.-K., Chang, P.-H., Kuo, W., Chen, C., Jeng, Y., Chang, K., Shew, J.-Y., Hu, C.-M., & Lee, W. (2017) · Nature Communications · doi:10.1038/ncomms14706 · Cited by 123
Wang, C., Wang, P.-J., Hsieh, Y.-C., Lo, S. J., Lee, Y.-C., Chen, Y.-C., Tsai, C., Chiu, W.-C., Hu, S. C., Lu, C.-W., et al. (2017) · Oncogene · doi:10.1038/onc.2017.357 · Cited by 123
Duong, M. N., Cleret, A., Matera, E., Chettab, K., Mathé, D., Valsesia‐Wittmann, S., Clemenceau, B., & Dumontet, C. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0569-0 · Cited by 117
Yang, Y., Zhang, Y., Iwamoto, H., Hosaka, K., Seki, T., Andersson, P., Lim, S., Fischer, C., Nakamura, M., Abe, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12680 · Cited by 114
Self-citationUeda, S., Saeki, T., Osaki, A., Yamane, T., & Kuji, I. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0874 · Cited by 106
Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy
Pramanik, R., Sheng, X., Ichihara, B., Heisterkamp, N., & Mittelman, S. D. (2013) · Leukemia Research · doi:10.1016/j.leukres.2012.12.013 · Cited by 105
Tumor angiogenesis and molecular targets for therapy
Cao, Y. (2009) · Frontiers in bioscience · doi:10.2741/3504 · Cited by 104
Self-citationHypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate
Norouzirad, R., González‐Muniesa, P., & Ghasemi, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5350267 · Cited by 103
Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.
Bolinder, J., Kerckhoffs, D. A. J. M., Moberg, E., Toft, E., & Arner, P. (2000) · Diabetes · doi:10.2337/diabetes.49.5.797 · Cited by 100
Small-Molecule Inhibitors of Human Ldh5
Granchi, C., Paterni, I., Rani, R., & Minutolo, F. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.151 · Cited by 99
Karataş, F., Erdem, G. U., Şahin, S., Aytekin, A., Yüce, D., Sever, A. R., Babacan, T., Ateş, Ö., Ozisik, Y. Y., & Altundağ, K. (2016) · The Breast · doi:10.1016/j.breast.2016.05.013 · Cited by 97
Steffens, S., Grünwald, V., Ringe, K. I., Seidel, C. A., Eggers, H., Schrader, M. G., Wacker, F., Kuczyk, M. A., & Schrader, A. J. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0213 · Cited by 91
Sage, F. L., Meilhac, O., & Gonthier, M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.022 · Cited by 90
A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
Liu, C., Zhang, Y., Lim, S., Hosaka, K., Yang, Y., Pavlova, T. V., Alkasalias, T., Hartman, J., Jensen, L. D., Xing, X., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0101 · Cited by 90
Self-citationOptimizing the Delivery of Cancer Drugs That Block Angiogenesis
Cao, Y., & Langer, R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000399 · Cited by 89
Self-citationLevitsky, A., Brismar, K., Hafström, I., Hambardzumyan, K., Lourdudoss, C., van Vollenhoven, R., & Saevarsdóttir, S. (2017) · RMD Open · doi:10.1136/rmdopen-2017-000458 · Cited by 89
Osman, M. A. M., & Hennessy, B. T. (2015) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s32812 · Cited by 87
Yang, D., Li, Y., Xing, L., Tan, Y., Sun, J., Zeng, B., Xiang, T., Tan, J., Ren, G., & Yang, D. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0221-6 · Cited by 85
Kobayashi, N., Barnard, R. J., SAID, J. W., Hong-Gonzalez, J., Corman, D. M., Ku, M., Doan, N., Gui, D., Elashoff, D. A., Cohen, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5616 · Cited by 81
Okumura, T., Ohuchida, K., Sada, M., Abe, T., Endo, S., Koikawa, K., Iwamoto, C., Miura, D., Mizuuchi, Y., Moriyama, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15430 · Cited by 77
Vargas, T., Moreno‐Rubio, J., Herránz, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3130 · Cited by 76
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer
Khalid, A., Wolfram, J., Ferrari, I., Mu, C., Mai, J., Yang, Z., Zhao, Y., Mauro Ferrari, B., Ma, X., & Shen, H. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955751513150923094709 · Cited by 75
Cao, Y., Zhong, W., & Sun, Y. P. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.001 · Cited by 74
Self-citationBartucci, M., Svensson, S., Ricci‐Vitiani, L., Dattilo, R., Biffoni, M., Signore, M., Ferla, R., Maria, R. D., & Surmacz, E. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0083 · Cited by 73
EGFRMutations and Sensitivity to Gefitinib
Rossi, G., Marchioni, A., & Longo, L. (2004) · New England Journal of Medicine · doi:10.1056/nejm200409163511221 · Cited by 72
Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
Buechler, C., & Weiß, T. S. (2011) · Current Drug Metabolism · doi:10.2174/138920011794520035 · Cited by 69
Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene CPT1C to Promote Survival
Reilly, P. T., & Mak, T. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3281 · Cited by 68
Bougaret, L., Delort, L., Billard, H., Lehuédé, C., Boby, C., Foye, A. D. L., Rossary, A., Mojallal, A. A., Damour, O., Auxenfans, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191571 · Cited by 68
Xiang, F., Wu, K., Liu, Y., et al. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.12.002 · Cited by 65
Amankwah, E. K., Saenz, A. M., Hale, G. A., & Brown, P. A. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1076815 · Cited by 64
Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response
Sheng, X., Tucci, J., Parmentier, J., Ji, L., Behan, J. W., Heisterkamp, N., & Mittelman, S. D. (2016) · Oncotarget · doi:10.18632/oncotarget.12246 · Cited by 64
Sheng, X., & Mittelman, S. D. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00053 · Cited by 63
Honek, J., Seki, T., Iwamoto, H., Fischer, C., Li, J., Lim, S., Samani, N. J., Zang, J., & Cao, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415825111 · Cited by 61
Self-citationDiet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice
Behan, J. W., Avramis, V. I., Yun, J. P., Louie, S. G., & Mittelman, S. D. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.007 · Cited by 59
Zhang, D., Hedlund, E., Lim, S., Chen, F., Zhang, Y., Sun, B., & Cao, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016220108 · Cited by 59
Self-citationCAR T-Cell Therapy in Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., & Go, W. Y. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1800913 · Cited by 58
Lin, T. (2019) · Cancer Management and Research · doi:10.2147/cmar.s199597 · Cited by 56
Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients
Arce-Salinas, C., Aguilar-Ponce, J. L., Villarreal-Garza, C. M., Lara-Medina, F. U., Olvera-Caraza, D., Miranda, A. A., Flores-Díaz, D., & Mohar, A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2977-8 · Cited by 55
Jiramongkolchai, P., Owens, P., & Hong, C. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160069 · Cited by 55
Castillo, J. J., Mulkey, F. A., Geyer, S. M., Kolitz, J. E., Blum, W. G., Powell, B. L., George, S. L., Larson, R. A., & Stone, R. M. (2015) · American Journal of Hematology · doi:10.1002/ajh.24230 · Cited by 54
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
Cascetta, P., Cavaliere, A., Piro, G., Torroni, L., Santoro, R., Tortora, G., Melisi, D., & Carbone, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113331 · Cited by 52
Chronic Pancreatitis and Pancreatic Cancer
Kong, X., Sun, T., Kong, F., Du, Y., & Li, Z. (2014) · Gastrointestinal Tumors · doi:10.1159/000365306 · Cited by 51
Oxidative damage to mitochondria in normal and cancer tissues, and its modulation
Kamat, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00279-1 · Cited by 48
Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development
Tan, J., Buache, É., Alpy, F., Daguenet, É., Tomasetto, C., Ren, G.-S., & Rio, M. C. (2013) · Oncogene · doi:10.1038/onc.2013.434 · Cited by 44
The role of bone marrow adipocytes in bone metastasis
Morris, E., & Edwards, C. (2016) · Journal of Bone Oncology · doi:10.1016/j.jbo.2016.03.006 · Cited by 44
Adipocytes Contribute to Resistance of Human Melanoma Cells to Chemotherapy and Targeted Therapy
Chi, M., Chen, J., Ye, Y.-S., Tseng, H., LAI, F.-J., Tay, K. H., Jin, L., Guo, S., Jiang, C., & Zhang, X. D. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131129114742 · Cited by 43
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model
Trédan, O., Lacroix‐Triki, M., Guiu, S., Mouret‐Reynier, M., Barrière, J., Bidard, F., Braccini, A.-L., Mir, O., Villanueva, C., & Barthélémy, P. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0334-9 · Cited by 42
IL-17 mediates resistance to anti-VEGF therapy
Maniati, E., & Hagemann, T. (2013) · Nature Medicine · doi:10.1038/nm.3333 · Cited by 40
The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma
Lu, Z., Liang, J., He, Q., Wan, Q., Hou, J., Lian, K., & Wang, A. (2019) · Clinical Science · doi:10.1042/cs20181023 · Cited by 35
Tumour-surrounding adipocytes are active players in breast cancer progression
Muller, C. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.02.007 · Cited by 33
Lim, S., Hosaka, K., Nakamura, M., & Cao, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9436 · Cited by 32
Self-citationZhang, D., Zhao, Y., Wang, T., Xi, Y., Li, N., & Huang, H. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2868 · Cited by 30
Gennari, A., Amadori, D., Scarpi, E., Farolfi, A., Paradiso, A., Mangia, A., Biglia, N., Gianni, L., Tienghi, A., Rocca, A., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3923-8 · Cited by 29
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
Arcidiacono, B., CHIEFARI, E. D., Laria, A. E., Messineo, S., Bilotta, F. L., Britti, D., FOTI, D. P., Foryst‐Ludwig, A., Kintscher, U., & Brunetti, A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i9.422 · Cited by 27
Osimertinib in EGFR Mutation–Positive Advanced NSCLC
Ward, M. C., Prabhu, R. S., & Burri, S. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1801669 · Cited by 27
IGF-1 from Adipose-Derived Mesenchymal Stem Cells Promotes Radioresistance of Breast Cancer Cells
Yang, H., Qu, R., Lin, X., Liu, T., Sun, Q., Yang, C., Li, X.-H., Lu, W., Hu, X., Dai, J., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.23.10115 · Cited by 25
Griner, S. E., Wang, K. J., Joshi, J. P., & Nahta, R. (2013) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/1875692111311010006 · Cited by 24
Coelho, P. P. O. L., Silva, L. M. R., de Faria, I. C. J., Vieria, M., Monteiro, A., Pinto, G., Prudêncio, C., Fernandes, R., & Soares, R. A. (2017) · Radiation Research · doi:10.1667/rr14551.1 · Cited by 17
Hematopoietic Stem Cell-derived Adipocytes Promote Tumor Growth and Cancer Cell Migration
Xiong, Y. (2017) · International Journal of Cancer Research and Molecular Mechanisms · doi:10.16966/2381-3318.130 · Cited by 17
Obesity Protects Cancer from Drugs Targeting Blood Vessels
Cao, Y. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.014 · Cited by 14
Self-citation
Cited by
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics
Morigny, P., Boucher, J., Arner, P., & Langin, D. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00471-8 · Cited by 527
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Yang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 494
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 392
Metadata
- Authors
- Cao, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2019-07-02
- Volume
- 129
- Issue
- 8
- Pages
- 3006-3017
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2954493501
- Cited by
- 522
- References
- 191
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.